-
1
-
-
0029953050
-
Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery
-
Rouge, N.; Buri, P.; Doelker, E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int. J. Pharm. 1996, 136, 117-139.
-
(1996)
Int. J. Pharm.
, vol.136
, pp. 117-139
-
-
Rouge, N.1
Buri, P.2
Doelker, E.3
-
2
-
-
0034117391
-
Prolonged gastric retention using floating dosage forms
-
Fell, J.T.; Whitehead, L.; Collet, H. Prolonged gastric retention using floating dosage forms. Pharm. Technol. March 2000, 24 (3), 82-90.
-
(2000)
Pharm. Technol. March
, vol.24
, Issue.3
, pp. 82-90
-
-
Fell, J.T.1
Whitehead, L.2
Collet, H.3
-
3
-
-
0026741035
-
Novel drug delivery system for captopril
-
Matharu, R.S.; Sanghavi, N.M. Novel drug delivery system for captopril. Drug Dev. Ind. Pharm. 1992, 18, 1567-1574.
-
(1992)
Drug Dev. Ind. Pharm.
, vol.18
, pp. 1567-1574
-
-
Matharu, R.S.1
Sanghavi, N.M.2
-
4
-
-
0011403448
-
Delivery systems for targeting to specific sites in the gastrointestinal tract
-
Fell, J.T. Delivery systems for targeting to specific sites in the gastrointestinal tract. J. Pharm. Pharmacol. 1999, 5 (Suppl.), 41.
-
(1999)
J. Pharm. Pharmacol.
, vol.5
, Issue.SUPPL.
, pp. 41
-
-
Fell, J.T.1
-
5
-
-
0033974459
-
Optimisation of floating matrix tablets and evaluation of their gastric residence time
-
Baumgartner, S.; Kristl, J.; Vrecer, F.; Vodopivec, P.; Zorko, B. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm. 2000, 195 (1-2), 125-135.
-
(2000)
Int. J. Pharm.
, vol.195
, Issue.1-2
, pp. 125-135
-
-
Baumgartner, S.1
Kristl, J.2
Vrecer, F.3
Vodopivec, P.4
Zorko, B.5
-
6
-
-
0029970924
-
Controlled-release drug delivery systems for prolonged gastric residence: An overview
-
Deshpande, A.A.; Rhodes, C.T.; Shah, N.H.; Malick, A.W. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug Dev. Ind. Pharm. 1996, 22 (6), 531-539.
-
(1996)
Drug Dev. Ind. Pharm.
, vol.22
, Issue.6
, pp. 531-539
-
-
Deshpande, A.A.1
Rhodes, C.T.2
Shah, N.H.3
Malick, A.W.4
-
7
-
-
0027509054
-
Helicobacter pylori and peptic ulcer disease
-
Ateshkadi, A.; Lam, N.; Johnson, C.A. Helicobacter pylori and peptic ulcer disease. Clin. Pharm. 1993, 12, 34-48.
-
(1993)
Clin. Pharm.
, vol.12
, pp. 34-48
-
-
Ateshkadi, A.1
Lam, N.2
Johnson, C.A.3
-
8
-
-
0037283432
-
The bactericidal effects of lactobacillus acidophilus, garcinol, and protykin compared to clarithromycin on Helicobacter Pylori
-
Chatterjee, A.; Yasmin, T.; Bagchi, D.; Stohs, S.J. The bactericidal effects of lactobacillus acidophilus, garcinol, and protykin compared to clarithromycin on Helicobacter Pylori. Mol. Cell Biochem. 2003, 243 (1-2), 29-35.
-
(2003)
Mol. Cell Biochem.
, vol.243
, Issue.1-2
, pp. 29-35
-
-
Chatterjee, A.1
Yasmin, T.2
Bagchi, D.3
Stohs, S.J.4
-
9
-
-
0028275918
-
Development of and evaluation of a monolithic floating dosage form for furosemide
-
Menon, A.; Wolfgang, A.; Ritschel, A.; Sakr, A. Development of and evaluation of a monolithic floating dosage form for furosemide. J. Pharm. Sci. 1994, 83, 239-245.
-
(1994)
J. Pharm. Sci.
, vol.83
, pp. 239-245
-
-
Menon, A.1
Wolfgang, A.2
Ritschel, A.3
Sakr, A.4
-
10
-
-
0031754109
-
Floating dosage forms: An in vivo study demonstrating prolonged gastric retention
-
Whitehead, L.; Fell, J.T.; Collett, J.H.; Sharma, H.L.; Smith, A.M. Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J. Control. Release 1998, 55 (1), 3-12.
-
(1998)
J. Control. Release
, vol.55
, Issue.1
, pp. 3-12
-
-
Whitehead, L.1
Fell, J.T.2
Collett, J.H.3
Sharma, H.L.4
Smith, A.M.5
-
11
-
-
0022654590
-
In vitro evaluation of alginate gel systems as sustained release drug delivery systems
-
Stockwell, A.F.; Davis, S.S.; Walker, S.E. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Control. Release 1986, 3, 167-175.
-
(1986)
J. Control. Release
, vol.3
, pp. 167-175
-
-
Stockwell, A.F.1
Davis, S.S.2
Walker, S.E.3
-
12
-
-
0030296212
-
In vivo evaluation of novel gastric retentive formulation based on ion-exchange resins
-
Atyabi, F.; Sharma, H.L.; Mohammed, H.A.H.; Fell, T.J. In vivo evaluation of novel gastric retentive formulation based on ion-exchange resins. J. Control. Release 1996, 42 (2), 105-113.
-
(1996)
J. Control. Release
, vol.42
, Issue.2
, pp. 105-113
-
-
Atyabi, F.1
Sharma, H.L.2
Mohammed, H.A.H.3
Fell, T.J.4
-
13
-
-
0024395207
-
Pharmaceutical factors influencing the rate of gastrointestinal transit in an animal model
-
Smart, J.D.; Kellaway, I.W. Pharmaceutical factors influencing the rate of gastrointestinal transit in an animal model. Int. J. Pharm. 1989, 53, 79-83.
-
(1989)
Int. J. Pharm.
, vol.53
, pp. 79-83
-
-
Smart, J.D.1
Kellaway, I.W.2
-
14
-
-
0036805566
-
Novel gastroretentive dosage forms: Evaluation of gastroretentivity and its effect on riboflavin absorption in dogs
-
Klausner, E.A.; Lavy, E.; Stepensky, D.; Friedman, M.; Hoffman, A. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm. Res. 2002, 19 (10), 1516-1523.
-
(2002)
Pharm. Res.
, vol.19
, Issue.10
, pp. 1516-1523
-
-
Klausner, E.A.1
Lavy, E.2
Stepensky, D.3
Friedman, M.4
Hoffman, A.5
-
15
-
-
0025042445
-
The influence of density on the gastrointestinal transit of pellets
-
Devereux, J.E.; Newton, J.M.; Short, M.B. The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol. 1990, 42, 500-501.
-
(1990)
J. Pharm. Pharmacol.
, vol.42
, pp. 500-501
-
-
Devereux, J.E.1
Newton, J.M.2
Short, M.B.3
-
16
-
-
0013883801
-
Factors affecting the absorption of riboflavin in man
-
Levy, G.; Juski, W.J. Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 1966, 55, 284-289.
-
(1966)
J. Pharm. Sci.
, vol.55
, pp. 284-289
-
-
Levy, G.1
Juski, W.J.2
-
17
-
-
0002332484
-
Antineoplastic agents
-
Hardman, J.G., Limbird, L.E., Eds.; McGraw-Hill: New York
-
Chabner, B.A.; Ryan, D.P.; Paz-Ares, L.; Garcia-Carbonero, R.; Calabresi, P. Antineoplastic agents. In The Goodman and Gilman's Pharmacological Basis of Therapeutics, 10th Ed.; Hardman, J.G., Limbird, L.E., Eds.; McGraw-Hill: New York, 2001; 1389-1460.
-
(2001)
The Goodman and Gilman's Pharmacological Basis of Therapeutics, 10th Ed.
, pp. 1389-1460
-
-
Chabner, B.A.1
Ryan, D.P.2
Paz-Ares, L.3
Garcia-Carbonero, R.4
Calabresi, P.5
-
18
-
-
0032898269
-
In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics
-
Pillay, V.; Fassihi, R. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. I. Comparison of pH-responsive drug release and associated kinetics. J. Control. Release 1995, 59, 229-242.
-
(1995)
J. Control. Release
, vol.59
, pp. 229-242
-
-
Pillay, V.1
Fassihi, R.2
-
19
-
-
2342652446
-
Mathematical comparison of dissolution profiles
-
Moore, J.W.; Flanner, H.H. Mathematical comparison of dissolution profiles. Pharm. Technol. 1996, 20 (6), 67-74.
-
(1996)
Pharm. Technol.
, vol.20
, Issue.6
, pp. 67-74
-
-
Moore, J.W.1
Flanner, H.H.2
-
20
-
-
0344893332
-
Mechanism of sustained action medication
-
Higuchi, T. Mechanism of sustained action medication. J. Pharm. Sci. 1963, 52, 1145-1149.
-
(1963)
J. Pharm. Sci.
, vol.52
, pp. 1145-1149
-
-
Higuchi, T.1
-
21
-
-
0034605983
-
Amoxicillin release from a floating dosage form based on alginates
-
Whitehead, L.; Collett, J.H.; Fell, J.T. Amoxicillin release from a floating dosage form based on alginates. Int. J. Pharm. 2000, 210, 45-49.
-
(2000)
Int. J. Pharm.
, vol.210
, pp. 45-49
-
-
Whitehead, L.1
Collett, J.H.2
Fell, J.T.3
|